(R)-Tegoprazan

CAS No. 942195-56-4

(R)-Tegoprazan( (R)-CJ-12420; (R)-RQ-00000004 )

Catalog No. M29649 CAS No. 942195-56-4

(R)-Tegoprazan (example 3), a benzimidazole derivative, is a potent kidney H+/K+-ATPase inhibitor with an IC50 of 98 nM of canine kidney Na+/K+-ATPase.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 826 In Stock
100MG 1768 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock

Biological Information

  • Product Name
    (R)-Tegoprazan
  • Note
    Research use only, not for human use.
  • Brief Description
    (R)-Tegoprazan (example 3), a benzimidazole derivative, is a potent kidney H+/K+-ATPase inhibitor with an IC50 of 98 nM of canine kidney Na+/K+-ATPase.
  • Description
    (R)-Tegoprazan (example 3), a benzimidazole derivative, is a potent kidney H+/K+-ATPase inhibitor with an IC50 of 98 nM of canine kidney Na+/K+-ATPase. (R)-Tegoprazan has the potential for gastrointestinal diseases research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (R)-CJ-12420; (R)-RQ-00000004
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Proton Pump
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    942195-56-4
  • Formula Weight
    387.38
  • Molecular Formula
    C20H19F2N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 50 mg/mL (129.07 mM; Need ultrasonic)
  • SMILES
    CN(C)C(C1=CC(O[C@H]2C3=C(F)C=C(F)C=C3OCC2)=C4C(N=C(N4)C)=C1)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Takeshi Hanazawa, et al. Chromane Substituted Benzimidazole Derivatives. US20070142448A1.
molnova catalog
related products
  • Ilaprazole sodium hy...

    Ilaprazole (IY-81149) sodium hydrate is an orally active proton pump inhibitor that irreversibly inhibits H+/K+-ATPase in rabbit parietal cells with a dose-dependent IC50 of 6 μM.

  • Ilaprazole

    A potent, orally active proton pump inhibitor that irreversibly inhibits H+/K(+)-ATPase with IC50 of 6 uM.

  • Esomeprazole sodium

    A proton pump inhibitor that reduces stomach acid secretion by inhibition of the H+/K+-ATPase in the parietal cells.